Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees.
Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees.
复制标题
DOI：
10.1016/j.jsat.2021.108464
复制
发表时间：
2021-12
影响因子：
3.9
通讯作者：
Kelly JF
中科院分区：
文献类型：
--
作者：
Hoffman LA;Vilsaint CL;Kelly JF
尽管阿片类药物已被证明有效，但阿片类药物使用障碍（MOUD）的药物利用不足。对MOUD的负面信念和态度相当普遍，但迅速扩大的康复社区中心（RCCs）可能为促进MOUD支持提供了一个有希望的场所，因为它们在“许多途径[恢复]，都应该庆祝”的格言下运作，并且主要由阿片类药物使用障碍患者使用。目前的研究提供了第一次看MOUD的态度和它们的相关性在RCC与会者。该研究对新英格兰31个RCC的康复成年人进行了横断面调查（N=320），评估人口统计学、治疗和康复相关因素，以及对使用激动剂和拮抗剂MOUD的态度（积极与消极）。该研究使用频率和置信区间来获得对激动剂和拮抗剂MOUD的积极和消极态度的患病率估计，并检查它们之间的差异。斯皮尔曼相关性确定了MOUD态度的相关性（p < 0.10），并通过多变量逻辑回归评估了显著相关性的独特贡献。对于激动剂（阳性：71.4 [66.1，76.3]%;阴性：28.6 [23.7，33.9]%）和拮抗剂（阳性：76.5 [71.4，81.1]%;阴性：23.5 [18.9，28.6]%）MOUD，积极态度普遍高于消极态度，两者无差异。该研究在p < 0.10的水平上确定了MOUD态度的几个相关因素，但只有四个变量成为控制其他相关因素的独特预测因素。激动剂MOUD治疗的终身史与积极的激动剂态度唯一相关（p=0.008），而更大的社会支持恢复与积极的拮抗剂态度相关（p=0.007）。较低的教育程度是唯一与消极的拮抗剂的态度（p=0.005），和更大程度的精神是与消极的态度，激动剂（p=0.005）和拮抗剂（p=0.01）。研究结果显示，RCC参与者中积极MOUD态度的比率非常高，突出了这种不断增长的恢复支持层的潜力，以促进对药物促进恢复途径的接受和同行支持。态度的相关性进一步揭示了在RCC网络内外促进MOUD接受的机会。
Despite their proven efficacy, medications for opioid use disorder (MOUD) are underutilized. Negative beliefs and attitudes toward MOUD are quite common, yet rapidly expanding recovery community centers (RCCs) may offer a promising venue for fostering MOUD support as they operate under the maxim, “many pathways [to recovery], all should be celebrated” and are utilized mainly by those with opioid use disorder. The current study provides a first look at MOUD attitudes and their correlates in RCC attendees. The study conducted a cross-sectional survey (N=320) of recovering adults attending 31 RCCs across New England, assessing demographic, treatment, and recovery-relevant factors, as well attitudes (positive vs. negative) toward the use of agonist and antagonist MOUD. The study used frequencies and confidence intervals to obtain prevalence estimates for positive and negative attitudes toward agonist and antagonist MOUD, and to examine differences between them. Spearman correlations identified correlates of MOUD attitudes (at p < 0.10), and significant correlates were assessed for unique contributions via multivariable logistic regression. Positive attitudes were common and more prevalent than negative attitudes for both agonist (positive: 71.4 [66.1, 76.3]%; negative: 28.6 [23.7, 33.9]%) and antagonist (positive: 76.5 [71.4, 81.1]%; negative: 23.5 [18.9, 28.6]%) MOUD, which did not differ. The study identified several correlates of MOUD attitudes at the p < 0.10 level, but only four variables emerged as unique predictors controlling for other correlates. Lifetime history of agonist MOUD treatment was uniquely associated with positive agonist attitudes (p=0.008), whereas greater social support for recovery was associated with positive antagonist attitudes (p=0.007). Lower educational attainment was uniquely associated with negative antagonist attitudes (p=0.005), and a greater degree of spirituality was related to negative attitudes toward both agonists (p=0.005) and antagonists (p=0.01). Findings reveal very high rates of positive MOUD attitudes among RCC participants, highlighting the potential for this growing tier of recovery support to foster acceptance and peer support for medication-facilitated recovery pathways. Correlates of attitudes further reveal opportunities for facilitating MOUD acceptance within and beyond the RCC network.
登录
查看更多内容
DOI：
10.1111/j.1530-0277.2010.01362.x
发表时间：
2011-03-01
影响因子：
3.2
作者：
Kelly, John F.;Stout, Robert L.;Pagano, Maria E.
通讯作者：
Pagano, Maria E.
对患者和提供者对阿片类药物使用障碍的治疗药物的观点的系统评价。
影响因子：
3.9
作者：
Cioe K;Biondi BE;Easly R;Simard A;Zheng X;Springer SA
通讯作者：
Springer SA
比较国家医疗学员医师和就读医师的全国样本中阿片类药物使用障碍的治疗观点。
影响因子：
4.2
作者：
Kennedy-Hendricks A;Barry CL;Stone E;Bachhuber MA;McGinty EE
通讯作者：
McGinty EE
影响因子：
--
作者：
Kessler, RC;Barker, PR;Zaslavsky, AM
通讯作者：
Zaslavsky, AM
影响因子：
2.6
作者：
Idler, EL;Musick, MA;Williams, DR
通讯作者：
Williams, DR